Value of Clinical Pulmonary Infection Score in guiding treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients
-
摘要: 目的 探讨临床肺部感染评分(CPIS)指导替加环素联合头孢哌酮钠舒巴坦钠治疗重症肺炎的价值。 方法 选取重症肺炎患者60例,随机分为2组,每组30例。对照组根据经验应用抗菌药治疗,观察组在CPIS指导下应用抗菌药治疗,用药方案均为替加环素联合头孢哌酮钠舒巴坦钠。比较2组症状消失率、抗菌药应用时间、炎症指标［C反应蛋白(CRP)、降钙素原(PCT)、白细胞计数(WBC)］水平及不良反应。 结果 治疗2周时, 2组患者发热症状均消失, 2组肺啰音、咳痰的消失率比较,差异无统计学意义(P>0.05)。观察组抗菌药应用时间为(7.38±2.66)d, 短于对照组的(9.82±2.89)d, 差异有统计学意义(t=3.403, P=0.001)。2组患者治疗后的CRP、PCT、WBC水平均较治疗前降低,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。 结论 在CPIS的指导下采用替加环素联合头孢哌酮钠舒巴坦钠治疗重症肺炎安全、有效,可缩短用药时间,缓解患者症状。Abstract: Objective To investigate the value of Clinical Pulmonary Infection Score(CPIS)in guiding the treatment of tigecycline combined with cefoperazone sodium and sulbactam sodium for severe pneumonia patients. Methods Totally 60 patients with severe pneumonia were selected and randomly divided into two groups, with 30 cases in each group. Control group was treated with antibiotics according to the experience, and observation group was treated with antibiotics under the guidance of CPIS. The drug regimen in both groups was tigecycline combined with cefoperazone sodium and sulbactam sodium. The symptom disappearance rate, application time of antibiotics, levels of inflammatory indexes［C reactive protein(CRP), procalcitonin(PCT), white blood cell count(WBC)］ and adverse reactions were compared between the two groups. Results After 2 weeks of treatment, the fever symptoms disappeared in both groups, and there were no significant differences in the disappearance rate of pulmonary rales and expectoration between the two groups(P>0.05). The application time of antibiotics in the observation group was(7.38±2.66)days, which was significantly shorter than(9.82±2.89)days in the control group(t=3.403, P=0.001). The levels of CRP, PCT and WBC in both groups after treatment were significantly lower than those before treatment(P<0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Under the guidance of CPIS, tigecycline combined with cefoperazone sodium and sulbactam sodium is safe and effective in the treatment of severe - pneumonia patients, which can shorten the medication time and relieve the symptoms of patients.
-
-
周欣, 姚高琼, 张成志, 等. 重庆市抗菌药物使用调查及干预前后对比分析研究[J]. 重庆医学, 2017, 46(11): 1508-1510. 黄丽君, 郑丽贞. 抗菌药物联合用药现状调查与研究[J]. 中国生化药物杂志, 2017, 37(7): 403-405. 刘华锋, 燕丽, 王磊, 等. 替加环素结合头孢哌酮钠舒巴坦钠治疗多药耐药鲍氏不动杆菌肺部感染患者的临床疗效[J]. 中华医院感染学杂志, 2017, 27(15): 3401-3403 , 3410.
LI T, SHENG M Y, GU T Z, et al. In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China[J]. Journal of Thoracic Disease, 2018, 10(3): 1370-1376.
CHEN C Q, YAN M L, HU C B, et al. Diagnostic efficacy of serum procalcitonin, C-reactive protein concentration and clinical pulmonary infection score in Ventilator-Associated Pneumonia[J]. Medecine Sciences: M/S, 2018, 34(Focus issue F1): 26-32.
石宏哲, 秦铮, 池卫华, 等. 重症肺炎MSCT图像征象、临床肺部感染评分与病情严重程度的相关性研究[J]. 中国CT和MRI杂志, 2019, 17(7): 79-81. 中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107. WONGSURAKIAT P, TULATAMAKIT S. Clinical pulmonary infection score and a spot serum procalcitonin level to guide discontinuation of antibiotics in ventilator-associated pneumonia: a study in a single institution with high prevalence of nonfermentative gram-negative bacilli infection[J]. Ther Adv Respir Dis, 2018, 12: 1753466618760134.
PFALLER M A, FLAMM R K, DUNCAN L R, et al. Antimicrobial activity of tigecycline and cefoperazone/sulbactam tested against 18, 386 Gram-negative organisms from Europe and the Asia-Pacific region(2013-2014)[J]. Diagnostic Microbiology and Infectious Disease, 2017, 88(2): 177-183.
CHEN H, LIU Q, CHEN Z, et al. Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: a systematic review and meta-analysis[J]. J Infect Chemother, 2017, 23(5): 278-285.
秦又发, 吴雷, 朱永坤, 等. 替加环素联合头孢哌酮-舒巴坦治疗广泛耐药鲍曼不动杆菌医院获得性肺炎临床疗效观察[J]. 中国感染与化疗杂志, 2015, 15(5): 430-433. GIAMMANCO A, CALÀ C, FASCIANA T, et al. Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial[J]. mSphere, 2017, 2(1): e00310-e00316.
CHEN Z, SHI X. Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens[J]. Medicine(Baltimore), 2018, 97(38): e12467.
聂晓莉, 闫春良, 赵秋红, 等. 医院内获得性肺炎抗菌药物的疗效和安全性比较[J]. 中国医院药学杂志, 2015, 35(13): 1225-1227. HARADA K, SEKIYA N, KONISHI T, et al. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation[J]. BMC Infectious Diseases, 2017, 17(1): 638-647.
GARDNER J G, BHAMIDIPATI D R, RUEDA A M, et al. White blood cell counts, alcoholism, and cirrhosis in pneumococcal pneumonia[J]. Open Forum Infectious Diseases, 2017, 4(2): ofx034.
ITO A, ISHIDA T, TOKUMASU H, et al. Impact of procalcitonin-guided therapy for hospitalized community-acquired pneumonia on reducing antibiotic consumption and costs in Japan[J]. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, 2017, 23(3): 142-147.
PANDURANGAN A P, ASCHER D B, THOMAS S E, et al. Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance[J]. Biochemical Society Transactions, 2017, 45(2): 303-311.
马莹, 李旺, 陈瑶, 等. 某院鲍氏不动杆菌耐药性与抗菌药物使用强度相关性分析[J]. 中华医院感染学杂志, 2020, 30(5): 648-652. 陈求凝, 张雪梅, 谢邦贵, 等. 不同抗菌药物对肺部感染新生儿肠道菌群及消化系统影响的研究[J]. 中华医院感染学杂志, 2018, 28(16): 2531-2534. -
期刊类型引用(32)
1. 冯利娜. 阶段性电话回访健康教育对肺癌PICC 置管化疗患者自护能力的影响. 内蒙古医学杂志. 2022(02): 239-240 . 
百度学术
2. 万媛，余婷婷，鲁捷，毛莉华. 基于Meleis转移理论的健康教育对肺癌化疗PICC带管患者出院准备度与自我管理能力的影响. 海南医学. 2022(11): 1486-1490 . 百度学术
3. 何欢，吴静，唐璐璐，刘利，刘晓玲. 基于FMEA的护理干预在PICC置管化疗恶性肿瘤患者中的应用效果. 中国当代医药. 2022(28): 185-188 . 百度学术
4. 王炎，陈瑞霞，王艳晓，冯媛. 静疗小组在非小细胞肺癌化疗患者PICC 置管中的应用价值分析. 内蒙古医学杂志. 2021(01): 112-113 . 百度学术
5. 史小娟. 临床护理路径模式在经外周静脉穿刺中心静脉置管化疗肺癌患者中的应用. 中国药物与临床. 2021(10): 1810-1812 . 百度学术
6. 张蕾，王艳香. 团体认知行为干预联合医护一体化正性暗示对血液病PICC置管患者心境状态及导管维护依从性的影响. 临床心身疾病杂志. 2021(01): 72-76 . 百度学术
7. 徐静，陈冬梅. 临床护理路径运用于肺癌患者PICC置管护理中的效果. 临床医药文献电子杂志. 2020(09): 84-85 . 百度学术
8. 刘荣，官敬荣. 细节护理对乳腺癌化疗置管患者自护能力及凝血功能的影响. 现代中西医结合杂志. 2020(11): 1251-1254 . 百度学术
9. 李桂芝. 肺癌化疗患者PICC置管中护理的应用效果分析. 中国医药指南. 2020(18): 237-238 . 百度学术
10. 彭春艳. 临床护理路径在原发性肺癌患者中的应用及效果评价. 当代医学. 2020(21): 57-59 . 百度学术
11. 苏丽花. 研究肺癌化疗患者PICC置管中护理的应用分析. 黑龙江中医药. 2020(03): 320-321 . 百度学术
12. 于博，谭盈盈. 循证护理在PICC置管化疗肺癌患者中的应用. 中国医药科学. 2020(08): 177-180 . 百度学术
13. 郑晓纯，范玉滢，杜爱红，马红艳. 临床护理路径在神经科痉挛性瘫痪患者改良PICC置管中的效果. 中国当代医药. 2020(30): 232-235 . 百度学术
14. 宁伟，李红. 微信平台在肺癌PICC化疗患者延伸护理中的应用. 实用临床护理学电子杂志. 2019(01): 94+97 . 百度学术
15. 薛霞，秦凤婷. 临床护理路径对肺癌化疗PICC置管患者依从性及并发症的影响. 中国民康医学. 2019(04): 166-168 . 百度学术
16. 黄芳芳. 临床护理路径在PICC置管肿瘤化疗患者中的应用效果. 中国当代医药. 2019(23): 202-204 . 百度学术
17. 胡茂珍，赵杰，顾丹凤，徐永萍，严小丽. 经皮穴位电刺激结合情绪释放疗法对肺癌化疗患者的影响. 齐鲁护理杂志. 2019(19): 31-34 . 百度学术
18. 钟苗苗. 改良优质护理措施在提高PICC置管成功率中的应用. 西藏医药. 2019(05): 116-117 . 百度学术
19. 陈晓玲. 临床护理路径应用在肺癌患者PICC置管中的效果观察及护理满意率影响评价. 中西医结合心血管病电子杂志. 2019(27): 109-110 . 百度学术
20. 姚蕊，牛红艳，邱煊惠，杨静. 网络互动平台的延伸护理服务对骨科肿瘤PICC置管化疗间歇期患者院外导管维护依从性的影响. 首都食品与医药. 2019(24): 159-160 . 百度学术
21. 李志飞. 临床护理路径在肺癌首次化疗病人中的应用效果分析. 当代临床医刊. 2019(06): 537+558 . 百度学术
22. 张丽霞，董兰. 临床护理路径预防重症颅脑损伤患者PICC相关并发症的效果. 国际护理学杂志. 2019(20): 3391-3395 . 百度学术
23. 杨梅兰. 护理团队干预对乳腺癌PICC化疗患者并发症及治疗依从性的影响. 护理实践与研究. 2018(12): 74-76 . 百度学术
24. 张丽萍，况丽根. 肺癌术后病人护理中临床护理路径的应用. 临床医药文献电子杂志. 2018(38): 112+116 . 百度学术
25. 祝文艳. 临床护理路径应用在肺癌患者PICC置管中的效果. 实用临床护理学电子杂志. 2018(30): 152-153 . 百度学术
26. 温静花，顾春芳，阐玉英. 癌症患者PICC留置期间健康促进行为现状及相关因素研究. 实用临床医药杂志. 2018(12): 58-61 . 本站查看
27. 谌红英. 临床护理路径在实体肿瘤化疗患者PICC管理中的效果评价. 黑龙江医药. 2018(05): 1182-1184 . 百度学术
28. 孙薇薇. 临床护理路径在肺癌化疗患者PICC置管管理中的应用. 中国医药指南. 2018(35): 241-242 . 百度学术
29. 刘小曼，单静雯，金小红. 自我效能干预在化疗间歇期患者PICC自我管理中应用价值研究. 贵州医药. 2018(12): 1533-1534 . 百度学术
30. 涂莹莹. 全程优质护理服务在肺癌手术护理中的应用效果. 现代诊断与治疗. 2018(23): 3911-3912 . 百度学术
31. 崔佳，张晓丹. PICC置管护理对肺癌患者导管血流感染的效果. 实用临床医药杂志. 2017(22): 139-140 . 本站查看
32. 赵佳. 肺癌化疗患者应用PICC置管护理的效果分析. 中国妇幼健康研究. 2017(S4): 521-522 . 百度学术
其他类型引用(3)
计量
- 文章访问数: 408
- HTML全文浏览量: 100
- PDF下载量: 15
- 被引次数: 35
下载:
苏公网安备 32100302010246号
